Your browser doesn't support javascript.
loading
Dupilumab efficacy in high sleep disturbance management among patients with type 2 asthma.
Maspero, Jorge F; Shafazand, Shirin; Cole, Jeremy; Pavord, Ian D; Busse, William W; Msihid, Jérôme; Gall, Rebecca; Soler, Xavier; Radwan, Amr; Khan, Asif H; de Prado Gómez, Lucia; Jacob-Nara, Juby A.
Affiliation
  • Maspero JF; Fundación CIDEA, Buenos Aires, Argentina. Electronic address: jorge.maspero@fundacioncidea.org.ar.
  • Shafazand S; University of Miami, Miami, FL, USA.
  • Cole J; OK Clinical Research, Edmond, OK, USA.
  • Pavord ID; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
  • Busse WW; University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Msihid J; Sanofi, Chilly-Mazarin, France.
  • Gall R; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
  • Soler X; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
  • Radwan A; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
  • Khan AH; Sanofi, Chilly-Mazarin, France.
  • de Prado Gómez L; Sanofi, Reading, UK.
  • Jacob-Nara JA; Sanofi, Bridgewater, NJ, USA.
Respir Med ; 218: 107344, 2023 11.
Article in En | MEDLINE | ID: mdl-37659435
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Anti-Asthmatic Agents Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Respir Med Year: 2023 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Anti-Asthmatic Agents Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Respir Med Year: 2023 Document type: Article Country of publication: Reino Unido